Log In
BCIQ
Print this Print this
 

SD-254

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionDeuterium-substituted version of venlafaxine, a selective serotonin-norepinephrine reuptake inhibitor (SNRI)
Molecular Target Serotonin (5-HT) transporter (SLC6A4) (SERT) ; Norepinephrine transporter
Mechanism of ActionNorepinephrine reuptake inhibitor; Selective serotonin reuptake inhibitor (SSRI)
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$3,500.0M

$3,500.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/05/2015

$3,500.0M

$3,500.0M

0

Get a free BioCentury trial today